Photo of: Newell Washburn

Dr. Newell Washburn

View Title...

Newell's profile was created using:
Sort By:

1-7 of 7 online sources for Newell Washburn

  • View Online Source
    www.kazakhstannews.net/story/395725 - [Cached Version]
    Published on: 8/18/2008    Last Visited: 8/18/2008  

    We're creating solutions to problems that can significantly impact people's quality of life,' said Newell Washburn, an assistant professor of biomedical engineering at Carnegie Mellon.

    'These gels have great promise in not only regenerating bone, but serving as a gene therapy delivery system,' he said.

  • View Online Source
    www.bmes.org/mc/page.do?sitePageId=81656&orgId=bes - [Cached Version]
    Last Visited: 5/15/2009  

    Newell Washburn (CMU) - washburn@andrew.cmu.edu

  • View Online Source
    www.regenerativemedicinetoday.com/cblog/index.php?/arch - [Cached Version]
    Published on: 9/1/2008    Last Visited: 10/11/2008  

    Regenerative Medicine Today welcomes Dr. Newell Washburn who is an Assistant Professor, in the Departments of Chemistry and Biomedical Engineering at Carnegie Mellon University.

    Dr. Washburn's primary research interests include wound healing and bone tissue engineering though the use of biomaterials that can used to form novel polymeric scaffolds for regenerative therapy, transport and interactions of signaling proteins with scaffolds and extracellular matrix.His focus is on creating materials capable of regulating the activities of soluble signaling proteins involved in inflammatory and immune responses.He discusses his current studies, and shares his vision on the application of these emerging technologies for clinical applications.

  • View Online Source
    Podcast Index - Regenerative Medicine Today - [Cached Version]
    Published on: 6/28/2007    Last Visited: 9/16/2009  

    Dr. Newell Washburn who is an Assistant Professor, in the Departments of Chemistry and Biomedical Engineering at Carnegie Mellon University.

  • View Online Source
    Regenerative Medicine Today - [Cached Version]
    Published on: 6/28/2007    Last Visited: 2/2/2009  

    Dr. Newell Washburn who is an Assistant Professor, in the Departments of Chemistry and Biomedical Engineering at Carnegie Mellon University.

  • View Online Source
    Regenerative Medicine Today #55 - Regenerative... - [Cached Version]
    Published on: 9/16/2009    Last Visited: 9/16/2009  

    Dr. Newell Washburn who is an Assistant Professor, in the Departments of Chemistry and Biomedical Engineering at Carnegie Mellon University. Regenerative Medicine Today #55 - Regenerative Medicine Today

    Regenerative Medicine Today #55
    ...
    Regenerative Medicine Today welcomes Dr. Newell Washburn who is an Assistant Professor, in the Departments of Chemistry and Biomedical Engineering at Carnegie Mellon University.

    Dr. Washburn's primary research interests include wound healing and bone tissue engineering though the use of biomaterials that can used to form novel polymeric scaffolds for regenerative therapy, transport and interactions of signaling proteins with scaffolds and extracellular matrix. His focus is on creating materials capable of regulating the activities of soluble signaling proteins involved in inflammatory and immune responses. He discusses his current studies, and shares his vision on the application of these emerging technologies for clinical applications.

  • View Online Source
    Regenerative Medicine Today #55 - Regenerative... - [Cached Version]
    Published on: 9/16/2009    Last Visited: 9/16/2009  

    Regenerative Medicine Today welcomes Dr. Newell Washburn who is an Assistant Professor, in the Departments of Chemistry and Biomedical Engineering at Carnegie Mellon University.

    Dr. Washburn's primary research interests include wound healing and bone tissue engineering though the use of biomaterials that can used to form novel polymeric scaffolds for regenerative therapy, transport and interactions of signaling proteins with scaffolds and extracellular matrix. His focus is on creating materials capable of regulating the activities of soluble signaling proteins involved in inflammatory and immune responses. He discusses his current studies, and shares his vision on the application of these emerging technologies for clinical applications.

Wrong Person?

Try these instead
Related searches
More...

Copyright © 2009 Zoom Information Inc. All rights reserved.

BBeachHead-2009-11-09_RC001.1 OM11